Intensity-modulated radiation therapy: emerging cancer treatment technology
Author Information
Author(s): Hong T S, Ritter M A, Tomé W A, Harari P M
Primary Institution: University of Wisconsin Medical School
Hypothesis
The use of intensity-modulated radiation therapy (IMRT) can improve dose conformality and reduce normal tissue toxicities in cancer treatment.
Conclusion
IMRT shows promise in reducing toxicity and improving outcomes in head and neck and prostate cancer treatments.
Supporting Evidence
- IMRT allows for improved shaping of radiation dose profiles around tumors while sparing normal tissues.
- Early reports suggest that IMRT can reduce xerostomia and improve quality of life for head and neck cancer patients.
- Studies indicate that IMRT can achieve high locoregional control rates in appropriately selected patients.
Takeaway
IMRT is a new way to give radiation therapy that helps protect healthy parts of the body while still treating cancer effectively.
Methodology
This review discusses the principles and clinical implementation of IMRT in treating head and neck and prostate cancers.
Potential Biases
There is a risk of significant heterogeneity in IMRT practice due to dependence on physics support and quality assurance.
Limitations
The clinical data on IMRT is still immature, with small patient numbers and varying treatment protocols.
Participant Demographics
The study includes patients with head and neck cancer and prostate cancer, with varying treatment backgrounds.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website